The US Plasma Fractionation Market is undergoing a transformative phase, projected to reach an impressive market size of $17 billion by 2035. This growth represents a significant leap from the estimated $8.5 billion in 2024, indicating a compound annual growth rate (CAGR) of 6.5%. As the demand for plasma-derived products rises due to increasing healthcare needs and advancements in medical...